AI Bias Analysis
4 models · Takes ~15 seconds
The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain peptides
Source
Stat News
Opens original article in a new tab
Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't actually necessary to achieve effective weight loss.
Another Elevidys trial, FDA reconsiders peptides, and other biotech news from The Readout
(MedPage Today) -- Kansas Gov. Laura Kelly (D) has signed new legislation that voids more than 20 years' worth of nursing board disciplinary actions, and overhauls the current nursing board. All board seats must be vacated by July 1, according...
(MedPage Today) -- A woman in Missouri was sentenced to 20 years in prison for stabbing a nurse and a paramedic. (First Alert 4) A basketball player in Ohio has filed suit alleging that Atiba Jackson, MD, performed arthroscopy on the wrong knee...
